口服避孕药的使用和宫腺癌
G Ursin1, R K Peters, B E Henderson
1Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles 90033-9987.
Lancet (London, England)
|November 19, 1994
概括
口服避孕药的使用与子宫腺癌的风险增加了一倍,特别是在长期使用超过12年的情况下. 这一发现突出了与口服避孕药相关的宫健康的潜在风险.
科学领域:
- 妇科瘤学 妇科瘤学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 在美国的年轻女性中,宫腺癌的发病率显著增加.
- 这一增长恰逢口服避孕药的广泛采用.
- 以前的研究表明,口服避孕药使用与这种癌症之间存在潜在联系.
研究的目的:
- 调查口服避孕药使用与子宫腺癌之间的关联.
- 为了确定口服避孕药的使用时间是否会影响宫腺癌的风险.
主要方法:
- 病例控制研究分析了洛杉矶县癌症监测计划 (1977-1991) 的数据.
- 包括195个宫腺癌病例和386个匹配的对照.
- 通过个人采访收集了详细的医学,性,避孕和生殖史.
主要成果:
- 与从未使用过口服避孕药的人相比,使用过口服避孕药与宫腺癌的风险增加了2.1倍.
- 超过12年的口服避孕药使用显示出最高的风险,调整后的几率比为4.4.
- 根据开始时的年龄,与怀孕相比的时间或一旦考虑持续时间的特定配方,没有发现显著的额外风险.
结论:
- 口服避孕药的使用,特别是长时间使用,是宫腺癌的重要危险因素.
- 这些发现表明需要进一步研究将口服避孕药与宫腺癌联系在一起的机制.
- 公共卫生战略可能需要考虑口服避孕药对宫癌风险的长期影响.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
10:42Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion
Published on: July 6, 2022
相关概念视频
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
